£95.00

CRC Press Developability of Biotherapeutics: Computational Approaches

78 black & white illustrations, 28 black

Price data last checked 46 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£95 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 45 days • 45 data points (No recent data available)

Historical
Generating forecast...
£147.18 £89.78 £102.31 £114.83 £127.35 £139.87 £152.40 14 March 2026 25 March 2026 05 April 2026 16 April 2026 27 April 2026

Price Distribution

Price distribution over 45 days • 3 price levels

Days at Price
Current Price
6 days · current 23 days 16 days 0 6 12 17 23 £95 £107 £147 Days at Price

Price Analysis

Most common price: £107 (23 days, 51.1%)

Price range: £95 - £147

Price levels: 3 different prices over 45 days

Description

Biopharmaceuticals are emerging as frontline medicines to combat several life-threatening and chronic diseases. However, such medicines are expensive to develop and produce on a commercial scale, contributing to rising healthcare costs. Developability of Biotherapeutics: Computational Approaches describes applications of computational and molecular modeling techniques that improve the overall process of discovery and development by removing empiricism. The concept of developability involves making rational choices at the pre-clinical stages of biopharmaceutical drug development that could positively impact clinical outcomes. The book also addresses a general lack of awareness of the many different contributions that computation can make to biopharmaceutical drug development. This informative and practical reference is a valuable resource for professionals engaged in industrial research and development, scientists working with regulatory agencies, and pharmacy, medicine, and life science students and educators. It focuses primarily on the developability of monoclonal antibody candidates, but the principles described can also be extended to other modalities such as recombinant proteins, fusion proteins, antibody drug conjugates and vaccines. The book is organized into two sections. The first discusses principles and applications of computational approaches toward discovering and developing biopharmaceutical drugs. The second presents best practices in developability assessments of early-stage biopharmaceutical drug candidates. In addition to raising awareness of the promise of computational research, this book also discusses solutions required to improve the success rate of translating biologic drug candidates into products available in the clinic. As such, it is a rich source of information on current principles and practices as well as a starting point for finding innovative applications of computation towards biopharmaceutical drug development.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Biologics and Biosimilars: Drug Discovery and Clinical Applications
97% match

Biologics and Biosimilars: Drug Discovery and Clinical Applications

CRC Press

£45.07 07 Feb 2026
Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)
96% match

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Springer

£160.00 13 Jan 2026
Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)
96% match

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

£179.10 13 Jan 2026
Emerging Protein Biotherapeutics
96% match

Emerging Protein Biotherapeutics

CRC Press

£128.23 02 May 2026
Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals
96% match

Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals

Wiley

£120.74 15 Feb 2026
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
96% match

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Springer

£95.00 10 Jun 2026
Drug Discovery and Development: Technology in Transition
96% match

Drug Discovery and Development: Technology in Transition

Churchill Livingstone

£47.99 02 May 2026
Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)
96% match

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)

CRC Press

£62.59 24 Feb 2026
Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)
96% match

Directory of Approved Biopharmaceutical Products (Pharmaceutical Science S)

CRC Press

£250.00 13 Jan 2026
Springer - Stability and Characterization of Protein Drugs Vol 5
96% match

Springer - Stability and Characterization of Protein Drugs Vol 5

Springer

£160.10 03 May 2026
Drug-Drug Interactions for Therapeutic Biologics
96% match

Drug-Drug Interactions for Therapeutic Biologics

Wiley

£96.38 05 Mar 2026
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
96% match

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Springer

£142.57 21 May 2026
The Challenge of CMC Regulatory Compliance for Biopharmaceuticals
96% match

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Springer

£160.28 22 Feb 2026
Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics
96% match

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Academic Press

£105.79 17 Feb 2026
Biosimilars and Interchangeable Biologics: Tactical Elements
96% match

Biosimilars and Interchangeable Biologics: Tactical Elements

CRC Press

£49.99 28 Feb 2026
Biopharmaceuticals: Challenges and Opportunities
96% match

Biopharmaceuticals: Challenges and Opportunities

CRC Press

£129.45 12 Jun 2026
Ligand-Binding Assays: Development, Validation, and Implementation in the Drug Development Arena
96% match

Ligand-Binding Assays: Development, Validation, and Implementation in the Drug Development Arena

Wiley

£102.99 27 Apr 2026
Biopharmaceuticals: Biochemistry and Biotechnology
96% match

Biopharmaceuticals: Biochemistry and Biotechnology

Wiley-Blackwell

£95.00 07 Mar 2026
Stability and Characterization of Protein and Peptide Drugs: Case Histories: 5 (Pharmaceutical Biotechnology, 5)
96% match

Stability and Characterization of Protein and Peptide Drugs: Case Histories: 5 (Pharmaceutical Biotechnology, 5)

Springer

£149.86 24 Apr 2026
Biosimilars and Interchangeable Biologics: Tactical Elements
96% match

Biosimilars and Interchangeable Biologics: Tactical Elements

CRC Press

£171.39 16 Feb 2026
New Frontiers in Chemical Biology: Enabling Drug Discovery: Volume 5 (Drug Discovery Series)
96% match

New Frontiers in Chemical Biology: Enabling Drug Discovery: Volume 5 (Drug Discovery Series)

Royal Society of Chemistry

£30.66 09 Mar 2026
Co- and Post-Translational Modifications of Therapeutic Antibodies and Proteins
96% match

Co- and Post-Translational Modifications of Therapeutic Antibodies and Proteins

Wiley

£102.70 01 Mar 2026
A Biotech Manager's Handbook: A Practical Guide (Woodhead Publishing Series in Biomedicine)
96% match

A Biotech Manager's Handbook: A Practical Guide (Woodhead Publishing Series in Biomedicine)

Woodhead Publishing

£105.00 09 Apr 2026
Case Studies in Modern Drug Discovery and Development
96% match

Case Studies in Modern Drug Discovery and Development

Wiley

£94.74 23 Jan 2026